SRZN

28.4607.21%
KC

K. Christopher Garcia

Co-Founder & Member of Scientific Advisory Board

Dr. K. Christopher Garcia, also known as Chris, Ph.D., has been a Professor of Molecular and Cellular Physiology and of Structural Biology at Stanford University School of Medicine since 1999. He has also been an Investigator with the Howard Hughes Medical Institute since 2005. He serves as a Science Partner at The Column Group, LLC and as a Scientific Advisor of Xaira Therapeutics, Inc. He is Co-Founder of 3T Biosciences, Inc. and serves as Chairman of its Scientific Advisory Board. He is Co-Founder of Surrozen, Inc. and serves as Chairman of its Scientific Advisory Board. He is Co-Founder of Synthekine and served as Chairman of its Scientific Advisory Board until 2026. He is Scientific Co-Founder of Mozart Therapeutics, Inc. and serves as a Member of its Scientific Advisory Board. He is Scientific Co-Founder of InduPro, Inc. and serves as its Director. He is a Co-founder of Eleven Biotherapeutics Inc. and ALXO. Dr. Garcia also serves on the Scientific Advisory Boards of Shanghai Henlius Biotech, Inc. since July 2023, Dispatch Biotherapeutics, Inc. and Arcus Biosciences, Inc. He served as a Member of the Scientific Advisory Board at Dragonfly Therapeutics, Inc. until June 2025 and at NGM Biopharmaceuticals, Inc. until 2019. He was previously an Ipartner at The Column Group, LLC. He also served on the Scientific Advisory Boards of Eleven Biotherapeutics, Inc. and the Immune Disease Institute, Inc. He was a postdoctoral fellow at Genentech, Inc. and The Scripps Research Institute. Dr. Garcia holds a Ph.D. in Biophysics from Johns Hopkins University School of Medicine and a B.S. in Biochemistry from Tulane University.

Positions